jbrown33	10.1200/JCO.2018.36.15_suppl.5563	<http://dx.doi.org/10.1200/jco.2018.36.15_suppl.5563>; rel="canonical"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.5563"><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/j-carl-barrett-3l83pxpgo6s3x"><j.3:name>J Carl Barrett</j.3:name><j.3:familyName>Barrett</j.3:familyName><j.3:givenName>J Carl</j.3:givenName></j.3:Person></j.0:creator><j.2:doi>10.1200/jco.2018.36.15_suppl.5563</j.2:doi><j.2:pageStart>5563</j.2:pageStart><j.0:publisher>American Society of Clinical Oncology (ASCO)</j.0:publisher><owl:sameAs rdf:resource="info:doi/10.1200/jco.2018.36.15_suppl.5563"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/tsveta-milenkova-3l83pxpgo6s3x"><j.3:name>Tsveta Milenkova</j.3:name><j.3:familyName>Milenkova</j.3:familyName><j.3:givenName>Tsveta</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jerry-s-lanchbury-3l83pxpgo6s3x"><j.3:name>Jerry S Lanchbury</j.3:name><j.3:familyName>Lanchbury</j.3:familyName><j.3:givenName>Jerry S</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="http://dx.doi.org/10.1200/jco.2018.36.15_suppl.5563"/><owl:sameAs rdf:resource="doi:10.1200/jco.2018.36.15_suppl.5563"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/michael-perry-3l83pxpgo6s3x"><j.3:name>Michael Perry</j.3:name><j.3:familyName>Perry</j.3:familyName><j.3:givenName>Michael</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/darren-r-hodgson-3l83pxpgo6s3x"><j.3:name>Darren R. Hodgson</j.3:name><j.3:familyName>Hodgson</j.3:familyName><j.3:givenName>Darren R.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jessica-s-brown-3l83pxpgo6s3x"><j.3:name>Jessica S Brown</j.3:name><j.3:familyName>Brown</j.3:familyName><j.3:givenName>Jessica S</j.3:givenName></j.3:Person></j.0:creator><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/0732-183X"><j.1:issn>1527-7755</j.1:issn><j.2:issn>1527-7755</j.2:issn><owl:sameAs>urn:issn:1527-7755</owl:sameAs><owl:sameAs>urn:issn:0732-183X</owl:sameAs><j.0:title>Journal of Clinical Oncology</j.0:title><j.1:issn>0732-183X</j.1:issn><j.2:issn>0732-183X</j.2:issn></j.2:Journal></j.0:isPartOf><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/eric-pujade-lauraine-3l83pxpgo6s3x"><j.3:name>Eric Pujade-Lauraine</j.3:name><j.3:familyName>Pujade-Lauraine</j.3:familyName><j.3:givenName>Eric</j.3:givenName></j.3:Person></j.0:creator><j.1:endingPage>5563</j.1:endingPage><j.1:doi>10.1200/jco.2018.36.15_suppl.5563</j.1:doi><j.1:startingPage>5563</j.1:startingPage><j.2:volume>36</j.2:volume><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#date" >2018-05-20</j.0:date><j.1:volume>36</j.1:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/charlie-gourley-3l83pxpgo6s3x"><j.3:name>Charlie Gourley</j.3:name><j.3:familyName>Gourley</j.3:familyName><j.3:givenName>Charlie</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/victor-abkevich-3l83pxpgo6s3x"><j.3:name>Victor Abkevich</j.3:name><j.3:familyName>Abkevich</j.3:familyName><j.3:givenName>Victor</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jonathan-a-ledermann-3l83pxpgo6s3x"><j.3:name>Jonathan A. Ledermann</j.3:name><j.3:familyName>Ledermann</j.3:familyName><j.3:givenName>Jonathan A.</j.3:givenName></j.3:Person></j.0:creator><j.0:title>Locus-specific loss of heterozygosity (LOH) in BRCA1/2 mutated (mBRCA) ovarian tumors from the SOLO2 (NCT01874353) and Study 19 (NCT00753545) clinical trials.</j.0:title><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/alexander-gutin-3l83pxpgo6s3x"><j.3:name>Alexander Gutin</j.3:name><j.3:familyName>Gutin</j.3:familyName><j.3:givenName>Alexander</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/kirsten-timms-3l83pxpgo6s3x"><j.3:name>Kirsten Timms</j.3:name><j.3:familyName>Timms</j.3:familyName><j.3:givenName>Kirsten</j.3:givenName></j.3:Person></j.0:creator><j.0:identifier>10.1200/jco.2018.36.15_suppl.5563</j.0:identifier><j.2:pageEnd>5563</j.2:pageEnd></rdf:Description></rdf:RDF>
